Abstract: MgSO 4 is used as a tocolytic agent. It is considered to be a calcium channel antagonist, but a different mechanism of its action might be involved. The aim of this study was to examine the contribution of calcium concentrations and potassium channels in the mechanism of MgSO 4 -mediated uterine relaxation. Isolated uteri from female Wister rats were treated with increasing MgSO 4 concentrations (0.1-30 mM). MgSO 4 induced dose-dependent inhibition of spontaneous activity. Addition of Ca 2+ (6 mM and 12 mM) stimulated uterine contractile activity and attenuated the inhibitory activity of MgSO 4 . In order to analyze the role of different subtypes of potassium channels, Ca 2+ -stimulated uteri were pretreated with glibenclamide (Glib), a selective ATP-sensitive potassium channel inhibitor (K ATP ), tetraethylammonium (TEA), a non-specific inhibitor of large conductance calcium-activated potassium channels (BK Ca ), and 4-aminopyridine (4-AP), a voltage-sensitive potassium channel inhibitor (Kv), at concentrations that had no effect per se. Pretreatment with 4-AP had no effect on MgSO 4 -mediated relaxation of Ca 2+ -stimulated uteri. The relaxing effect of MgSO 4 was potentiated by pretreatment with glibenclamide. Pretreatment with TEA attenuated the MgSO 4 -mediated decrease in frequency. Our results suggest that MgSO 4 acts as a general calcium antagonist that influences Ca 2+ -mediated potassium channels. Furthermore, it seems that MgSO 4 uterine relaxation activity is partially mediated by selective ATP-sensitive potassium channels, suggesting an ATP-dependent role.
INTRODUCTION
Magnesium sulfate (MgSO 4 , mineral salt, soluble in water) is used as a laxative, tocolytic agent and it is known as a functional blocker of calcium channels [1, 2] . Despite the long-standing experience of its application, the use of MgSO 4 in gynecology has been a source of controversy for years. MgSO 4 was first used in 1906 to prevent eclamptic attacks by Horn in Germany, when administered intrathecally [3] . Its intramuscular use was first performed in 1926 to prevent repeated attacks in women with eclampsia [4] , while the first intravenous administration was in 1933 to women with eclampsia and preeclampsia [5] .
The tocolytic effects of MgSO 4 were originally described by Hall et al. in 1959 [6] . Stallworth et. al. (1981) found a slight decrease in the incidence of uterine contractions, but no significant change in the intensity of contractions during MgSO 4 administration [7] . Meta-analysis has shown that that magnesium reduces the risk of birth within 48 h by 15%, but it is considered not significant [8] . However, a combination of a betamimetic agonist and MgSO 4 has been introduced, and studies have shown its efficiency in prolonging gestation [9] [10] [11] . On the other hand, tocolytic efficacy was not improved and side effects were increased [12] . Although there are many studies dealing with the tocolytic effect of MgSO 4 , the exact mechanism of its action is still unknown.
Different types of β2-adrenergic agonists, Ca 2+ channel blocker, oxytocin receptor antagonist and nonsteroidal antiinflammatory drugs are also used as tocolytics, but their insufficient effectiveness and side effects compromise their preliminary use [13, 14] . Therefore, agents with potential tocolytic characteristics are still needed, and they could include calcium antagonists, potassium channel openers and other vasodilators [15] . Potassium channels are abundant and active in the smooth muscle of the uterus [16] [17] [18] . Based on structure and function, the channels are categorized in different groups (Kv channels, BK Ca channels, ATPsensitive potassium channels), and each group contains many subtypes and isoforms [19] . Large conductance calcium-activated potassium channels (BK Ca ) are dominant and active in uterine smooth muscles, especially during gestation [20] . ATP-dependent potassium channels (K ATP ) in the smooth muscles of the uterus form the connection between the metabolic state of the cell and uterine contractility [20, 21, 22] . Therefore, studying the influence of potassium channel modulators on uterine tissue has been suggested as important for finding new therapeutic concepts in the treatment of uterine contractility disturbances [15, 23] .
Although wide-scale examinations of drugs as modulators of contractility have been performed, a final therapeutic preference has been omitted [17, 23, 24] . MgSO 4 is considered a general calcium antagonist, but the potential site of MgSO 4 cellular physiological activity can also be at the level of potassium channels. Potassium channels are widespread in all living cells and very important for regulating cell membrane excitability [25] . Therefore, the aim of our study was to explore the effect of MgSO 4 on uterine contractility with regard to the role of calcium concentrations and potassium channels.
MATERIALS AND METHODS

Experimental system
All animals were treated according to directive 2010/63/ EU of the European Parliament on the protection of animals used for scientific purposes and experiments were approved by the Ethical Committee for the Use of Laboratory Animals of the Faculty of Medicine Foča, University of East Sarajevo, Decision No. 01-3-88. Animals were kept at 22°C, housed 3 per cage and fed ad libitum. Uteri from intact Wistar rats (250-300 g) in the estrus phase of the estrus cycle, determined by examination of a daily vaginal lavage [26] , were used. 
Reagents
Isolated organ bath studies
All rats were killed by rapid decapitation. The uterine horns were rapidly excised, carefully cleaned of surrounding connective tissue and mounted vertically in a 10-mL-volume organ bath containing De Jalon's solution (NaCl 154 mM, KCl 5.6 mM, CaCl 2 × 2H 2 O 0.41 mM, NaHCO 3 5.9 mM and glucose 2.8 mM), under 1 g tension, aerated with 95% oxygen and 5% CO 2 at 37°C. Experiments were performed after an equilibration period of about 30 min. The effect of MgSO 4 was examined on a spontaneously active uterus (incubated for 30 min in an organ bath in De Jalon's solution at 37°C, oxygenated with 95% of O 2 and 5% CO 2 ), as well as on calcium-stimulated (6 and 12 mM Ca 
Data analysis and statistical procedures
Statistical analyses (descriptive statistics, analysis of variance (ANOVA), post hoc tests, F-test and Student's t test) were performed according to the protocols de-scribed by Hinkle et al. [27] and Manley [28] . Effects of the treatments on uterine contractions were calculated as the percentages of untreated control contractions. Each value is expressed as the mean±SD. Differences between groups were analyzed by two-way ANOVA on a logarithmic transformed data row, using concentrations and pretreatments as factors (ANOVA was considered statistically significant when p<0.05), and post hoc tested by Tukey's HSD t-test. Since concentration-response curves were sigmoidal in shape, they were fitted according to Boltzmann functions (the concentration axis was logarithmic) and the EC 50 were calculated. Sigmoid curves were compared using the F-test. EC 50 values were compared using Student's t test (significance: p<0.05).
RESULTS
MgSO4 relaxed spontaneous uterine activity in a concentration-dependent manner with regard to frequency (Fig. 1A ). There were no significant changes in amplitude until complete cessation of contractions occurred (at the highest used MgSO 4 concentration of 30 mM). Fig. 1D ). EC 50 was 5 times higher for double Ca 2+ -stimulated uteri than for the spontaneously active uterus. The addition of both single and double Ca 2+ extended the MgSO 4 -induced relaxation effect and shifted the sigmoid shape for the frequency toward higher concentrations (significant F-test effect, p<0.05; Fig. 1D ).
Pretreatment with 4-AP had no effect on MgSO 4 -mediated relaxation of Ca 2+ -stimulated uteri (no significant ANOVA pretreatment effect, no difference between either the sigmoidal fit curve shape or EC 50 ; Fig. 2A and B) . On the other hand, a relaxing effect of MgSO 4 was potentiated by pretreatment with glibenclamide ( Fig. 3A and B) . Pretreatment with glibenclamide significantly deepened relaxation by decreasing frequency (significant ANOVA pretreatment effect, p<0.05). Pretreatment with glibenclamide lowered the concentrations of MgSO 4 that were needed for relaxation (post hoc Tukey difference between degrees of relaxation by single equivalent concentration of 5 and 10 mM). There was no difference between the MgSO 4 -induced relaxing effect of Ca 2+ -stimulated and glibenclamide pretreated uteri as regards the amplitude.
Pretreatment with TEA led to the elevation of frequency (significant ANOVA pretreatment effect, p<0.001; Fig. 4A and 4B) after application of MgSO 4 concentrations above 1 mM (post hoc Tukey t test, p<0.001). However, there was no statistically significant difference between EC 50 values for frequency since there were large distributions of data in the middle part of the TEA curve and therefore the SD was high. There was no difference between the MgSO 4 -relaxing effect of Ca 2+ -stimulated and TEA pretreated uteri regarding amplitude.
DISCUSSION
Our results showed that MgSO 4 inhibited spontaneous uterine activity in a concentration-dependent manner, and that therefore it could be considered as a uterine relaxant. This effect was in the range from 1-30 mM in the ex vivo extra uterine fluid (the EC 50 for frequency was 2.6 mM). These external MgSO 4 concentrations are not toxic, but pharmacologically they are selective with regard to the dosage, i.e. the therapeutic window is rather narrow. Magnesium ion concentrations in the plasma and extracellular fluid are approximately 1.2-1.4 mM. One-third is bound by albumin or other proteins and biochemical moieties [29] . This means that small increases in Mg 2+ in the extra uterine fluid can slow down the spontaneous frequency, but for complete relaxation a 3-fold higher concentration is required. Literature data indicate that increasing human serum Mg 2+ concentration by 4-6 mEq/L (2-3 mmol/L) decreases uterine activity in preterm labor [30] . However, our results with pretreatment with glibenclamide and TEA indicated that the effective MgSO 4 concentration range might be under the influence of applied drugs that can shift its therapeutic potential. Our study showed that the addition of Ca 2+ to the isolated organ bath prior to MgSO 4 significantly attenuated the relaxing effect of MgSO 4 . Addition of the single Ca 2+ concentration provoked an increase of the force of spontaneous contractions by elevating both amplitude and frequency. This increase was additionally elevated by the double concentration Ca 2+ . In both cases, MgSO 4 inhibited contractile activity, suggesting its physiological role as a general Ca 2+ antagonist. It is known that Mg 2+ inhibits the ryanodine receptor (RyR) Ca 2+ -release channels by competing with Ca 2+ at the cytosolic activation sites of the channel in the mM range [31] [32] [33] and influences the fidelity of coupling between L-type Ca 2+ channels and RyRs [34] . On the other hand, cytosolic levels of H + , Ca 2+ , adenine nucleotides and Mg 2+ during fatigue influence the gating properties of the SR Ca 2+ channel [35] , and the functional roles of the three main intracellular ions, Na + , Ca 2+ and Mg 2+ , are modulated by calmodulin connected voltage-gated Na + channels [36] .
Since increasing concentrations of Ca 2+ inhibited the relaxing effect of MgSO 4 only in part, this indicated the existence of additional cellular signaling pathways that Mg 2+ could operate through. Therefore, we partially inhibited potassium channels by different inhibitors prior to the addition of MgSO 4 . Our results showed that the voltage-gated K V subfamilies of potassium channels K V 1-K V 4 were not involved in the inhibitory action of Mg 2+ , since pretreatment with 4-AP had no effect on concentration-dependent Mg 2+ -promoted uterine relaxation. On the other hand, pretreatment with TEA modified the relaxing activity of MgSO 4 . TEA is a potent inhibitor of voltage-gated K V 1-K V 4 subfamilies of potassium channels, but it also inhibits K V 7 (KCQN) as well as BK Ca potassium channel subfamilies, suggesting that KCQN as well as BK Ca channels operated during the MgSO 4 -induced relaxant effect. In our experiment, pretreatment with TEA attenuated the relaxing effect as regards the frequency. Given that XE991, a KCNQ channel inhibitor, elevated the frequency of the murine myometrium [37] , it seems that the partial blockade of the potassium channels' pore by TEA in our experiment contributed to the elevated frequency, and that MgSO 4 operated as a mild KCQN channel inhibitor. It is known that intracellular Mg 2+ enhances the function of BK Ca potassium channels [38] through distinct binding sites and the activation is not directly affected either by voltage or Ca 2+ . However, TEA is also an efficient blocker of this type of channel, and its suppression contributed to other mechanisms of Mg 2+ -induced inhibition of uterine contractility. Moreover, BK Ca channels are in neuronal cells colocalized with voltage-dependent Ca 2+ channels [39, 40, 41] or RYR [42] , and these functional couples seem to be responsive to the Ca 2+ entering into the cytosol and to the control Ca 2+ concentration [40, 42, 43] . Shi and Cui [38] within the cytoplasm and the mitochondrial matrix as well [45, 46] . Our results showed that a partial blockade of K ATP channels by glibenclamide stimulated the relaxing activity of MgSO 4 , which points to its ATPdependent role.
The results presented in our study show that MgSO 4 acts only partially as a general calcium antagonist. Moreover, a part of its physiological pathway is through BK Ca channels since the blocking of BK Ca channels with TEA led to the stimulation of frequency. Since relaxing activity was predominantly achieved by the reduction of frequency, it seems that MgSO 4 is a direct K + channel inhibitor, but it also affects Ca 2+ availability. Furthermore, the MgSO 4 uterine relaxing activity is influenced by selective ATP-sensitive potassium channels suggesting also an ATP-dependent role. 
